UK markets closed

RTW Biotech Opportunities Ltd (RTW.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.3150-0.0050 (-0.38%)
At close: 04:09PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) 505.86M
Enterprise value N/A
Trailing P/E 3.65
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.52
Price/book (mrq)1.18
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 37.32%
S&P500 52-week change 322.38%
52-week high 31.9000
52-week low 31.0500
50-day moving average 31.3175
200-day moving average 31.2770

Share statistics

Avg vol (3-month) 3958.8k
Avg vol (10-day) 3497.21k
Shares outstanding 5384.69M
Implied shares outstanding 6384.69M
Float 8N/A
% held by insiders 112.26%
% held by institutions 111.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 1,994.76%
Operating margin (ttm)-69.18%

Management effectiveness

Return on assets (ttm)-0.47%
Return on equity (ttm)21.42%

Income statement

Revenue (ttm)4.17M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)55.50%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)83.19M
Diluted EPS (ttm)0.3600
Quarterly earnings growth (yoy)-21.30%

Balance sheet

Total cash (mrq)2.72M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)6.35
Book value per share (mrq)1.90

Cash flow statement

Operating cash flow (ttm)33.54M
Levered free cash flow (ttm)-63.61M